Anti-Depressant Fluoxetine Reveals its Therapeutic Effect Via Astrocytes
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Although psychotropic drugs act on neurons and glial cells, how glia respond, and whether glial responses are involved in therapeutic effects are poorly understood. Here, we show that fluoxetine (FLX), an anti-depressant, mediates its anti-depressive effect by increasing the gliotransmission of ATP. FLX increased ATP exocytosis via vesicular nucleotide transporter (VNUT). FLX-induced anti-depressive behavior was decreased in astrocyte-selective VNUT-knockout mice or when VNUT was deleted in mice, but it was increased when astrocyte-selective VNUT was overexpressed in mice. This suggests that VNUT-dependent astrocytic ATP exocytosis has a critical role in the therapeutic effect of FLX. Released ATP and its metabolite adenosine act on P2Y 11 and adenosine A2b receptors expressed by astrocytes, causing an increase in brain-derived neurotrophic factor in astrocytes. These findings suggest that in addition to neurons, FLX acts on astrocytes and mediates its therapeutic effects by increasing ATP gliotransmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“It is well known that the majority of BDNF is produced by neurons [42] as well as microglial”
BackgroundNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“What is the mechanism(s) underlying the ATP-mediated BDNF production in astrocytes? In neurons, SSRIs increase extracellular 5-HT, upregulating neuronal BDNF in a 5-HT receptor-dependent manner [4].”
BackgroundThe Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · cited 1×
“In general, major depression is thought to be caused by the dysfunction of monoaminergic neurons, because a number of antidepressants exert their primary biochemical effects by inhibiting the reuptake of 5-HT and/or noradrenaline [15].”
BackgroundShimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 1×
“BDNF has received increasing attention as a therapeutic target for depression because BDNF levels were reduced in mood disorders and preclinical depressionmodels [33, 56], chronic treatmentwith anti-depressants increased brain BDNF gene expression and signaling [9], treatment with anti-depressants increased BDNF in se…”
BackgroundAstrocyte-derived ATP modulates depressive-like behaviors
Cao, X., Li, L.-P., Wang, Q., Wu, Q., Hu, H.-H., Zhang, M., Fang, Y.-Y., Zhang, J., Li, S.-J., Xiong, W.-C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3162 · Cited by 615
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · cited 1×
“For example, loss of glia but not neuronswas sufficient to induce depressive-like behavior in rats [2], and FLX counteracted astrocytic cell loss in an animal model of depression [17].”
BackgroundIdentification of a vesicular nucleotide transporter
Sawada, K., Echigo, N., Juge, N., Miyaji, T., Otsuka, M., Omote, H., Yamamoto, A., & Moriyama, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800141105 · Cited by 418
Self-citationCotrina, M. L., Lin, J. H.-C., López-Garcı́a, J. C., Naus, C. C. G., & Nedergaard, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02835.2000 · Cited by 388
Cited by
Fang, Y., Ding, X., Zhang, Y., Cai, L., Ge, Y., Ma, K., Xu, R., Li, S., Song, M., Zhu, H., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02389-y · Cited by 96
Wang, Y., Ni, J., Gao, T., Gao, C., Guo, L., & Yin, X. (2020) · Glia · doi:10.1002/glia.23850 · Cited by 42
Li, Z., Lu, Y., Liang, S., Li, S., Chen, B., Zhang, M., Xia, M., Guan, D., Verkhratsky, A., & Li, B. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104689 · Cited by 21
Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants
Verkhratsky, A., Parpura, V., Scuderi, C., & Li, B. (2021) · Advances in Neurobiology · doi:10.1007/978-3-030-77375-5_13 · Cited by 19
Evaluation of the antidepressive property of β-hydroxybutyrate in mice
Pan, S., Hu, P., You, Q., Chen, J., Wu, J., Zhang, Y., Cai, Z., Ye, T., Xu, X., Chen, Z., et al. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000535 · Cited by 12
Metadata
- Authors
- Kinoshita, M., Hirayama, Y., Fujishita, K., Shibata, K., Shinozaki, Y., Shigetomi, E., Takeda, A., Le, H. P. N., Hayashi, H., Hiasa, M., Moriyama, Y., Ikenaka, K., Tanaka, K. F., & Koizumi, S.
- Venue
- EBioMedicine
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 32
- Pages
- 72-83
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W2805858388
- Cited by
- 115
- References
- 13
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-Depressant Fluoxetine Reveals its Therapeutic Effect Via Astrocytes. https://app.cochat.ai/papers/10.1016/j.ebiom.2018.05.036
- The paper
- Kinoshita, M., Hirayama, Y., Fujishita, K., Shibata, K., Shinozaki, Y., Shigetomi, E., Takeda, A., Le, H. P. N., Hayashi, H., Hiasa, M., Moriyama, Y., Ikenaka, K., Tanaka, K. F., & Koizumi, S. (2018). Anti-Depressant Fluoxetine Reveals its Therapeutic Effect Via Astrocytes. EBioMedicine. https://doi.org/10.1016/j.ebiom.2018.05.036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.